CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 9 No. 7
 

New Report Lists 218 Known or Likely Human Carcinogens

July 1, 2000

BETHESDA, Md—The number of substances “known” or “reasonably anticipated” to cause human cancer now stands at 218, according to the newly published Report on Carcinogens, 9th edition. The new number represents a total increase of 14 substances over the 8th edition. Sixteen substances were added to the previous list, and, for the first time, two were removed.

Report on Carcinogens, which Congress first ordered prepared in 1978, is published every 2 years by the National Toxicology Program (NTP), headquartered at the National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC.

The purpose of the report is to identify potential cancer hazards, and it does not take into account potential benefits of substances. Some oncologic drugs, for example, are listed because their use can lead to second cancers.

“People should not make decisions concerning the use of a given drug, or any other listed agent, based solely on the information contained in the report,” NTP warned. “Decisions of this type should be made only after consulting with a physician or other appropriate specialist about both risks and benefits.”

The artificial sweetener saccharin and ethyl acrylate, which is used in making latex paints and textiles, were both removed from the list of substances “reasonably anticipated to be a human carcinogen.” Saccharin had been listed in the report since 1981 and ethyl acrylate since 1989.

“Two decades ago, when saccharin was shown to produce bladder tumors in rats, it was a prudent, protective step to consider the sweetener to be a likely human carcinogen,” said NIEHS director Kenneth Olden, PhD, who also heads the NTP. “However, our understanding of the science has advanced and allows us to make finer distinctions today. Studies now indicate that the rat bladder tumors arise from mechanisms that are not relevant to the human situation.”

As for ethyl acrylate, new studies have shown that the tumors found in animals developed only when the chemical was given orally in high concentrations, which resulted in persistent and severe gastric tissue injury.

Saccharin and ethyl acrylate were the first substances removed from the list since NTP established a formal delisting procedure in 1996.

New on the List

Newly listed in the report and given “known human carcinogen” status are environmental tobacco smoke, tobacco smoking, and smokeless tobacco; consumption of alcohol(Drug information on alcohol)ic beverages; and solar ultraviolet radiation and exposure to sunlamps and sunbeds (tanning beds).

Tamoxifen(Drug information on tamoxifen) (Nolvadex) was also added to the list, based on studies that show the drug causes uterine cancer.

“There has been concern expressed that the listing of tamoxifen in the 9th Report could raise concerns among patients regarding its use for cancer treatment or prevention,” the NTP said. “In this instance, the benefits of exposure to the substance have been determined by the FDA to outweigh the risks entailed. . . It is very important that the public and physicians be aware of potential risks so that they have the necessary knowledge to weight the benefits versus the risks of using tamoxifen.”

Two other new listings are strong inorganic acid mists containing sulfuric acid, used in the manufacture of isopropyl alcohol, lead batteries, phosphate fertilizers, soap and detergents, synthetic ethanol, and pickling and other acid treatments of metals, and dyes metabolized to benzidine, used mainly for dyeing textiles and paper.

TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) has been proposed for upgrade to the “known to be a human carcinogen” category, but the proposed listing is currently in litigation.

Upgraded to Known Carcinogen

Substances upgraded from the “reasonably anticipated” list to “known human carcinogen” are:

  • Crystalline silica of respirable size, primarily quartz dust occurring in industrial and occupational settings.

  • 1,3-Butadiene, used in making synthetic rubber.

  • Cadmium and cadmium compounds, found in batteries, plastics, synthetic products, and alloys.

  • Ethylene oxide, used in making other chemicals and for sterilizing medical devices.

Six substances were added to the “reasonably anticipated” list:

  • Diesel exhaust particulates, based on findings of elevated lung cancer rates in occupational groups exposed to diesel exhaust, including railroad, bus garage, and trucking company workers.

  • Isoprene, a major component of natural rubber used in making synthetic rubbers and found in tobacco smoke and automobile exhaust.

  • Chloroprene, used primarily in making elastomer polychloroprene (neoprene).

  • Phenolphthalein, used as a laboratory reagent and acid-base indicator, and formerly as an ingredient in over-the-counter laxatives.

  • Tetrafluoroethylene, used in the production of many polymers.

  • Trichloroethylene, primarily a degreaser of metal parts and once used to decaffeinate coffee.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy